Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;72(9):1315-1322.
doi: 10.1002/acr.24014.

Association of Sjögren's Syndrome With Reduced Lifetime Sex Hormone Exposure: A Case-Control Study

Sara S McCoy  1 , Emmanuel Sampene  1 , Alan N Baer  2
Affiliations

Association of Sjögren's Syndrome With Reduced Lifetime Sex Hormone Exposure: A Case-Control Study

Sara S McCoy et al. Arthritis Care Res (Hoboken). 2020 Sep.

Abstract

Objective: To test whether cumulative estrogen exposure, as determined by age at menarche, age at menopause, female hormone use, hysterectomy, and parity, have an effect on the development of primary Sjögren's syndrome (SS).

Methods: We performed a case-control study of 2,680 women from the Sjögren's International Collaborative Clinical Alliance registry, including 1,320 registrants with primary SS and 1,360 with sicca symptoms but no key features of primary SS (sicca controls). The composite estrogen score (CES) was calculated by point assignment for early menarche (age ≤10 years), high parity (>3 pregnancies), hysterectomy, female hormone use, and late menopause (age ≥53 years). Cumulative menstrual cycling (CMC) was calculated as years menstruating minus time pregnant.

Results: Using a regression model that adjusted for age, recruitment site, ethnicity, education, employment status, and smoking, we observed a progressive inverse trend between primary SS and CES. The odds ratio (OR) and 95% confidence interval (95% CI) were as follows for the sicca control group: CES 1, OR 0.81 (95% CI 0.67-0.99); CES 2, OR 0.74 (95% CI 0.57-0.97); CES 3, OR 0.50 (95% CI 0.30-0.86). This trend was corroborated by analysis of CMC. At the highest level of CMC within the postmenopausal group there was a 24% reduction in cumulative sex hormone exposure among primary SS participants relative to controls.

Conclusion: Women with primary SS have lower estrogen exposure and CMC compared to sicca controls. Increasing estrogen exposure was negatively associated with development of primary SS. Further longitudinal studies of sex hormone exposure in primary SS are needed to confirm these findings.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest statement:The authors of this paper have no current financial support or other benefits from commercial sources for the reported work, or any other financial interests which could create a potential conflict of interest or appearance of a conflict of interest with regard to the work.

References

    1. Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjogren’s syndrome: a systematic review and meta-analysis. Annals of the rheumatic diseases. 2015;74(11):1983–9. - PubMed
    1. Valtysdottir ST, Wide L, Hallgren R. Low serum dehydroepiandrosterone sulfate in women with primary Sjogren’s syndrome as an isolated sign of impaired HPA axis function. The Journal of rheumatology. 2001;28(6):1259–65. - PubMed
    1. Gutierrez MA, Anaya JM, Scopelitis E, Citera G, Silveira L, Espinoza LR. Hyperprolactinaemia in primary Sjogren’s syndrome. Annals of the rheumatic diseases. 1994;53(6):425. - PMC - PubMed
    1. Laroche M, Borg S, Lassoued S, De Lafontan B, Roche H. Joint pain with aromatase inhibitors: abnormal frequency of Sjogren’s syndrome. The Journal of rheumatology. 2007;34(11):2259–63. - PubMed
    1. Priori R, Medda E, Conti F, Cassara EA, Sabbadini MG, Antonioli CM, et al. Risk factors for Sjogren’s syndrome: a case-control study. Clinical and experimental rheumatology. 2007;25(3):378–84. - PubMed

Publication types